Stent thrombosis with drug-eluting and bare-metal stents

The Lancet

Volumn 380, Issue 9842, 2012, Pages 646-

  Haine, Steven E F ^a   Vrints, Christiaan J M ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; COBALT; EVEROLIMUS;

AERATION; BALLOON DILATATION; BARE METAL STENT; CARDIOVASCULAR RISK; DRUG ELUTING STENT; HUMAN; LETTER; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RISK FACTOR; STENT THROMBOSIS;

EID: 84865153170     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61365-8     Document Type: Letter

References (4)

1. Palmerini T, Biondi-Zoccai G, Della Riva D, et al. Stent thrombosis with drug-eluting and baremetal stents: evidence from a comprehensive network meta-analysis. Lancet 2012; 379: 1393-402.
2. Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2005; 45: 995-98.
3. van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol 2009; 53: 1399-409.
4. von Birgelen C, Basalus MW, Tandjung K, et al. A randomized controlled trial in secondgeneration zotarolimus-eluting resolute stents versus everolimus-eluting xience v stents in real-world patients: the TWENTE trial. J Am Coll Cardiol 2012; 59: 1350-61.